Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 7, 2014; 20(25): 8244-8252
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8244
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8244
Table 1 Case characteristics n (%)
| Characteristic | Complication group | F/χ2 | P value | |||
| No (n = 446) | Grade I (n = 105) | Grade II (n = 106) | Grade III (n = 94) | |||
| Age (yr) | 24.064 | < 0.001 | ||||
| ≤ 65 | 239 (53.6) | 74 (70.5) | 39 (36.8) | 50 (53.2) | ||
| > 65 | 207 (46.4) | 31 (29.5) | 67 (63.2) | 44 (46.8) | ||
| Gender | 10.265 | 0.016 | ||||
| Male | 302 (67.7) | 62 (59.0) | 83 (78.3) | 69 (73.4) | ||
| Female | 144 (32.3) | 43 (41.0) | 23 (21.7) | 25 (26.6) | ||
| Other diseases | 34.383 | < 0.001 | ||||
| No | 358 (80.3) | 87 (82.9) | 70 (66.0) | 52 (55.3) | ||
| Yes | 88 (19.7) | 18 (17.1) | 36 (34.0) | 42 (44.7) | ||
| BMI (kg/m2) | 14.640 | 0.002 | ||||
| Normal | 348 (78.0) | 83 (79.0) | 72 (67.9) | 58 (61.7) | ||
| Abnormal | 98 (22.0) | 22 (21.0) | 34 (32.1) | 36 (38.3) | ||
| Laboratory findings | ||||||
| WBC (102/mm3) | 6.5 ± 2.1 | 6.4 ± 2.3 | 6.6 ± 2.3 | 6.4 ± 2.2 | 0.311 | 0.733 |
| Serum albumin (mg/dL) | 40.3 ± 5.7 | 40.1 ± 5.0 | 41.1 ± 5.6 | 40.2 ± 6.0 | 0.700 | 0.497 |
| Tumor size (mm) | 3.728 | 0.292 | ||||
| < 5 cm | 178 (39.9) | 46 (43.8) | 36 (34.0) | 31 (33.0) | ||
| ≥ 5 cm | 268 (60.1) | 59 (56.2) | 70 (66.0) | 63 (67.0) | ||
| Intraoperative blood loss (mL) | 9.875 | 0.020 | ||||
| < 200 | 211 (47.3) | 55 (52.4) | 39 (36.8) | 33 (35.1) | ||
| ≥ 200 | 235 (52.7) | 50 (47.6) | 67 (63.2) | 61 (64.9) | ||
| Tumor location | 23.550 | 0.005 | ||||
| Lower 1/3 | 204 (45.7) | 11 (10.5) | 40 (37.7) | 27 (28.7) | ||
| Middle 1/3 | 48 (10.8) | 11 (10.5) | 9 (8.5) | 10 (10.6) | ||
| Upper 1/3 | 111 (24.9) | 57 (54.3) | 39 (36.8) | 36 (38.3) | ||
| 2/3 or more | 83 (18.6) | 26 (24.8) | 18 (17.0) | 21 (22.3) | ||
| Histology | 5.596 | 0.133 | ||||
| Differentiated | 147 (33.0) | 27 (25.7) | 43 (40.6) | 34 (36.2) | ||
| Undifferentiated | 299 (67.0) | 78 (74.3) | 63 (59.4) | 60 (63.8) | ||
| Extranodal metastasis | 17.533 | 0.001 | ||||
| Positive | 70 (15.7) | 18 (17.1) | 19 (17.9) | 32 (34.0) | ||
| Negative | 376 (84.3) | 87 (82.9) | 87 (82.1) | 62 (66.0) | ||
| Serosal invasion | 3.734 | 0.292 | ||||
| No | 90 (20.2) | 25 (23.8) | 18 (17.0) | 13 (13.8) | ||
| Yes | 356 (79.8) | 80 (76.2) | 88 (83.0) | 81 (86.2) | ||
| Lymph node metastasis | 23.866 | 0.005 | ||||
| pN0 | 129 (28.9) | 32 (30.5) | 35 (33.0) | 14 (14.9) | ||
| pN1 | 57 (12.8) | 17 (16.2) | 14 (13.2) | 28 (29.8) | ||
| pN2 | 112 (25.1) | 20 (19.0) | 23 (21.7) | 20 (21.3) | ||
| pN3 | 148 (33.2) | 36 (34.4) | 34 (32.1) | 32 (34.0) | ||
| TNM stage | 39.915 | < 0.001 | ||||
| I | 35 (7.8) | 12 (11.4) | 7 (6.6) | 4 (4.3) | ||
| II | 101 (22.6) | 28 (26.7) | 23 (21.7) | 22 (23.4) | ||
| III | 291 (65.2) | 62 (59.0) | 61 (57.5) | 50 (53.2) | ||
| IV | 19 (4.3) | 3 (2.9) | 15 (14.2) | 18 (19.1) | ||
| Chemotherapy | 19.76 | < 0.001 | ||||
| Yes | 261 (58.5) | 72 (68.6) | 45 (42.5) | 43 (45.7) | ||
| No | 185 (41.5) | 33 (31.4) | 61 (57.5) | 51 (54.3) | ||
| Type of gastrectomy | 1.004 | 0.800 | ||||
| Subtotal | 315 (70.6) | 71 (67.6) | 74 (32.4) | 62 (66.0) | ||
| Total | 131 (29.4) | 34 (32.4) | 32 (30.2) | 32 (34.0) | ||
- Citation: Jiang N, Deng JY, Ding XW, Zhang L, Liu HG, Liang YX, Liang H. Effect of complication grade on survival following curative gastrectomy for carcinoma. World J Gastroenterol 2014; 20(25): 8244-8252
- URL: https://www.wjgnet.com/1007-9327/full/v20/i25/8244.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i25.8244